TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINI…
Research this with AI
Ask AI researches this public topic. CaptureIQ qualifies the opportunity, manages the pursuit, and prepares review-ready materials.
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75N91024F00002
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $760,552
- Period of performance
- Jun 17, 2024 – Jun 16, 2026
Public award description
TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS
Related intelligence
- Contractor: UNIVERSITY OF OKLAHOMA
- Agency: Department of Health and Human Services
- Federal market intelligence software
Related Federal Awards
- · 75N91022F00002 — TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,435,788
- · 75N91025F00001 — BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,234,179
- · 75N92023F00001 — STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - P… · DEFINITIVE LOGIC CORPORATION · Department of Health and Human Services · $1,218,378
- · 75N91022F00004 — CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUA… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,201,554
- · 75N91026F00001 — TRIPLE NEGATIVE BREAST CANCER VACCINES · Department of Health and Human Services · $1,147,754
- · 75N91023F00001 — BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BI… · MEDIDATA SOLUTIONS, INC. · Department of Health and Human Services · $1,140,397